Suppr超能文献

Mineralocorticoid antagonists and ENaC inhibitors in hyperaldosteronism.

作者信息

Hill Michael A, Sowers James R

机构信息

Diabetes and Cardiovascular Center, Dalton Cardiovascular Research Center, VA Medical Center, University of Missouri School of Medicine, Columbia, Missouri.

出版信息

J Clin Hypertens (Greenwich). 2019 Jul;21(7):929-931. doi: 10.1111/jch.13566. Epub 2019 Jun 6.

Abstract
摘要

相似文献

1
Mineralocorticoid antagonists and ENaC inhibitors in hyperaldosteronism.
J Clin Hypertens (Greenwich). 2019 Jul;21(7):929-931. doi: 10.1111/jch.13566. Epub 2019 Jun 6.
2
4
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism.
Ann Endocrinol (Paris). 2016 Jul;77(3):226-34. doi: 10.1016/j.ando.2016.01.010. Epub 2016 Jun 14.
5
Comparison of agents that affect aldosterone action.
Semin Nephrol. 2014 May;34(3):285-306. doi: 10.1016/j.semnephrol.2014.04.005. Epub 2014 Apr 18.
6
Mineralocorticoid receptor antagonists and endothelial function.
Curr Opin Investig Drugs. 2008 Sep;9(9):963-9.

引用本文的文献

1
Emerging Role of Leptin in Vascular and Placental Dysfunction in Preeclampsia.
Arterioscler Thromb Vasc Biol. 2025 May;45(5):585-599. doi: 10.1161/ATVBAHA.124.321676. Epub 2025 Apr 3.
2
Comparison of different medical treatments for primary hyperaldosteronism: a systematic review and network meta-analysis.
Ther Adv Chronic Dis. 2024 Mar 19;15:20406223241239775. doi: 10.1177/20406223241239775. eCollection 2024.
3
Sensory Nutrition and Bitterness and Astringency of Polyphenols.
Biomolecules. 2024 Feb 17;14(2):234. doi: 10.3390/biom14020234.
4
Salt Sensitivity of Blood Pressure in Women.
Hypertension. 2023 Feb;80(2):268-278. doi: 10.1161/HYPERTENSIONAHA.122.17952. Epub 2022 Aug 23.
5
Primary aldosteronism.
Gland Surg. 2020 Feb;9(1):14-24. doi: 10.21037/gs.2019.10.23.

本文引用的文献

1
Long-term BP control and vascular health in patients with hyperaldosteronism treated with low-dose, amiloride-based therapy.
J Clin Hypertens (Greenwich). 2019 Jul;21(7):922-928. doi: 10.1111/jch.13567. Epub 2019 Jun 6.
2
Multifaceted Functions of Epithelial Na Channel in Modulating Blood Pressure.
Hypertension. 2019 Feb;73(2):273-281. doi: 10.1161/HYPERTENSIONAHA.118.12330.
3
Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.
Hypertension. 2018 Sep;72(3):537-548. doi: 10.1161/HYPERTENSIONAHA.118.11065.
4
Epithelial Sodium Channel in Aldosterone-Induced Endothelium Stiffness and Aortic Dysfunction.
Hypertension. 2018 Sep;72(3):731-738. doi: 10.1161/HYPERTENSIONAHA.118.11339.
5
Potential Role of Antihypertensive Medications in Preventing Excessive Arterial Stiffening.
Curr Hypertens Rep. 2018 Jul 6;20(9):76. doi: 10.1007/s11906-018-0876-9.
6
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.
Lancet Diabetes Endocrinol. 2018 Jan;6(1):41-50. doi: 10.1016/S2213-8587(17)30319-4. Epub 2017 Nov 9.
7
Epithelial Na Channel Regulation by Extracellular and Intracellular Factors.
Annu Rev Physiol. 2018 Feb 10;80:263-281. doi: 10.1146/annurev-physiol-021317-121143. Epub 2017 Nov 9.
8
Dendritic Cell Amiloride-Sensitive Channels Mediate Sodium-Induced Inflammation and Hypertension.
Cell Rep. 2017 Oct 24;21(4):1009-1020. doi: 10.1016/j.celrep.2017.10.002.
9
Amiloride Improves Endothelial Function and Reduces Vascular Stiffness in Female Mice Fed a Western Diet.
Front Physiol. 2017 Jun 30;8:456. doi: 10.3389/fphys.2017.00456. eCollection 2017.
10
Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females.
Circ Res. 2016 Mar 18;118(6):935-943. doi: 10.1161/CIRCRESAHA.115.308269. Epub 2016 Feb 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验